CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer
Year: 2026
Type: article
Abstract: Background: CD97 is overexpressed in various cancers, but its function and immunoregulatory role in triple-negative breast cancer (TNBC) remain unclear. This study aimed to investigate the expression, function, and potential regulatory mechanisms of CD97 in TNBC. Methods: CD97 expression, clinical associations, and immune infiltration were evaluated using TCGA, KM Plotter, and GEO bulk, single-cell, and spatial transcriptomic datasets. THP-1-derived M1a/M1b macrophage models with CD97 knockdown or overexpression were used to assess phagocytosis, cytokine secretion, and effects on tumor and endothelial cells. Zinc modulation, NF-κB inhibition, Western blotting, pseudotime analysis, transcription-factor screening, and network analyses were used to explore potential mechanisms. Results: CD97 was upregulated in TNBC and enriched in M1 macrophages. In a pooled KM Plotter analysis, high CD97 expression was associated with favorable relapse-free survival; however, CD97 was not significantly associated with overall survival in the TCGA-TNBC cohort in univariable or stage-adjusted Firth Cox analyses. In M1a macrophages, CD97 perturbation altered phagocytic activity, tumor-cell apoptosis, intracellular zinc homeostasis, and NF-κB signaling, with pharmacological inhibition supporting NF-κB as a downstream mediator. In M1b macrophages, CD97 knockdown increased, whereas overexpression decreased, MDA-MB-231 migration and invasion in vitro. SPI1 perturbation altered CD97 expression, supporting SPI1 as a potential upstream regulator rather than establishing direct transcriptional control. Conclusion: CD97 is associated with immune-active features in TNBC and modulates macrophage functions in vitro. Its prognostic relevance appears context- and dataset-dependent, and further in vivo and clinical validation is required before translational application.
Source: Journal of Inflammation Research
DOI: 10.2147/jir.s620455
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W7225304494
